Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Sanofi
02 1TAPI Technology & API Services
03 1Boehringer Ingelheim GmbH
04 1Curia
05 1Lek Pharmaceuticals
06 2Olon S.p.A
07 1Teva Pharmaceutical Industries
01 1France
02 1Germany
03 2Israel
04 2Italy
05 1Slovenia
06 1U.S.A
01 4Active
02 3Inactive
03 1Blank
01 2Valid
02 1Withdrawn by Holder
03 5Blank
01 8Blank
01 8Blank
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3169
Submission : 1978-03-06
Status : Inactive
Type : II
TAPI offers customized CDMO Solutions for API development and manufacturing services.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-05-31
Pay. Date : 2012-11-07
DMF Number : 14944
Submission : 2000-06-28
Status : Active
Type : II
Certificate Number : R1-CEP 2005-107 - Rev 02
Issue Date : 2022-11-07
Type : Chemical
Substance Number : 551
Status : Valid
| Available Reg Filing : ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30497
Submission : 2016-04-15
Status : Active
Type : II
NDC Package Code : 17337-0061
Start Marketing Date : 2015-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-03-06
Pay. Date : 2018-09-28
DMF Number : 33022
Submission : 2018-09-27
Status : Active
Type : II
NDC Package Code : 17337-0061
Start Marketing Date : 2015-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-09-29
Pay. Date : 2013-09-24
DMF Number : 22407
Submission : 2009-01-13
Status : Active
Type : II
Certificate Number : R1-CEP 2000-183 - Rev 08
Issue Date : 2023-03-08
Type : Chemical
Substance Number : 551
Status : Valid
NDC Package Code : 55486-1587
Start Marketing Date : 2012-06-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10242
Submission : 1993-04-26
Status : Inactive
Type : II
Certificate Number : R1-CEP 2001-268 - Rev 01
Issue Date : 2015-11-03
Type : Chemical
Substance Number : 551
Status : Withdrawn by Holder
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16194
Submission : 2002-10-17
Status : Inactive
Type : II
NDC Package Code : 47848-006
Start Marketing Date : 2017-11-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
A Dihydroergotamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydroergotamine, including repackagers and relabelers. The FDA regulates Dihydroergotamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydroergotamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dihydroergotamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dihydroergotamine supplier is an individual or a company that provides Dihydroergotamine active pharmaceutical ingredient (API) or Dihydroergotamine finished formulations upon request. The Dihydroergotamine suppliers may include Dihydroergotamine API manufacturers, exporters, distributors and traders.
click here to find a list of Dihydroergotamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 7 companies offering Dihydroergotamine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
